Navigation Links
Patients Should Expect 'Long Life' from their Joint Replacements!

GLEN COVE, N.Y., Sept. 8 /PRNewswire/ -- In response to the news that DePuy Orthopaedics, the manufacturer of an artificial hip system, issued a recall of its ASR product line after data indicated a higher than expected need for device replacement surgery five years after the initial procedure, Dr. Eugene S. Krauss, chairman of the Department of Orthopedics and director of the Orthopedic and Rehabilitation Institute at Glen Cove Hospital, a member of the North Shore-LIJ Health System, states:

"This news should not alarm anyone who has had their joint replacement performed at The Center for Joint Replacements at Glen Cove Hospital, Southside Hospital, or Peconic Bay Medical Center, as we are not using any of these components. A properly positioned hip or knee replacement, done well, in a true center of excellence, by surgeons who are highly experienced, can last many decades. High tech implants are predominantly modular, and therefore replacing worn out bearings can be a relatively simple procedure."Today's technology offers remarkably durable, long-term solutions, and if a hospital insists on using the very best technology, patients can anticipate many years of success."Patients are looking for good long-term solutions: It is far more cost effective to have your surgery performed by a highly skilled team using the best implants available in America. Do it once. Do it well...and allow the patient to return to an active and long life."

Dr. Krauss continues, "If you want the best outcome, three factors must be in place: 1. A highly experienced surgeon who is part of a comprehensive joint program. 2. A surgeon associated with a Health System that enables him to use the highest quality implants made in America. 3. A post-operative Rehab program with therapists who will place the patient back on the road to recovery. The most successful outcomes are achieved by combining the best surgical team, a comprehensive rehabilitation program, and a motivated patient. We look for patients who 'have places to go and things to do' and want to get back to enjoying life."

Dr. Krauss, who has personally performed over 10,000 joint replacements, will be celebrating patients' successful return to mobility at the Road to Mobility Gala to be held at the Pratt Pavilion for Rehabilitation & Healing at the Glengariff Healthcare Center in Glen Cove, Long Island on September 14, 2010. Guests will have the opportunity to see video footage and hear Dr. Krauss recount the remarkable impact The Krauss Foundation for Health & Humanity has had on the less fortunate across the globe.Eugene S. Krauss, M.D., FAAOS, FACS, is a graduate of Columbia's College of Physicians and Surgeons. He completed residencies in orthopedics at the Hospital for Special Surgery and Memorial Sloan-Kettering Cancer Center. Fellowships abroad included orthopedic reconstructive surgery in Basel, Switzerland, and pelvic and acetabular fracture fixation and reconstruction in Paris. Dr. Krauss was appointed Chief of Orthopedic Trauma at North Shore University Hospital and was subsequently named Chairman of Orthopedics. Soon after coming to North Shore University Hospital, Dr. Krauss established the Musculoskeletal Institute, a multidisciplinary affiliate, and served as CEO, President, Medical Director and Surgeon-in-Chief for five years. As a result of the institute's success, Dr. Krauss went on to form the Orthopedic and Rehabilitation Institute at Glen Cove Hospital, a member of the North Shore-LIJ Health System. At Glen Cove Hospital he is Chairman of the Department of Orthopedics and Director of the Orthopedic and Rehabilitation Institute. In 2006, Dr. Krauss founded the Center for Joint Replacements, where he serves as Director. Contact:Ruth Folger

SOURCE The Krauss Center for Joint Replacement
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmacists May Help Patients Prevent and Detect Heart Disease
2. CVS Caremark to Offer $5 Million in Free Flu Shots to Uninsured Patients of Community Clinics and Health Centers Beginning September 20
3. MAP Pharmaceuticals Announces All Non-Asthmatic Patients Complete Treatment in Open-Label Trial and Completion of Treatment in QT Trial for LEVADEX™ Clinical Program
4. First AXL1717 Clinical Data From Ongoing Phase I/II Study in Cancer Patients has Been Published
5. NACDS, NCPA: Victory for Patients, Pharmacy as CMS Moves to Withdraw Provisions of AMP Rule Currently Blocked by Injunction
6. Elbit Imaging Announces Insightec Treats First Prostate Cancer Patients in Clinical Trials
7. Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain
8. Genetic Substudy Shows Fewer Major Cardiovascular Events With Ticagrelor (BRILINTA) Regardless of Relevant Genetic Variability in ACS Patients
9. Sermo Report Indicates that Ticagrelor is Likely to Affect the Standard of Care for ACS Patients
10. Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients
11. Veteran Affairs Announces That Redsense Alarm Will be Mandatory on Patients by November 1, 2010
Post Your Comments:
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):